Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
WHO is likely to decide on EUL of Covaxin in four to six weeks
According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during…
Slashed GST rates on COVID-related items: The stakeholder view
In a recent development, the GST Council reduced the rates of COVID essentials, including drugs for treatment and other related…
Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes
It is a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR…
Unichem Labs gets tentative US FDA approval for Sitagliptin Tablets USP
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes…
ICMR proposes clinical trial along with Oxford University to evaluate COVID-19 therapy
The trial -- 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)'-- will be a multi-centre, adaptive platform trial on…
Study notes COVID-19 most likely caused by animal source, not of lab origin
The study noted that while a laboratory accident "cannot be entirely dismissed", there currently exists zero evidence for such a…
Working with Moderna to see make its COVID vaccine available in India: Govt
Moderna's COVID-19 vaccine was granted emergency use authorisation last month
Microbiome-targeting treatment is set to evolve, address multiple immunological indications:…
Out of the 23 drugs in the pipeline, 13 are being investigated for GI indications, with the majority targeting ulcerative colitis…
Rubicon Research acquires MeditabSpecialities’ facility in Satara, Maharashtra
The facility manufactures oral liquid dosage and nasal products
Alembic Pharmaceuticals gets USFDA final approval for Erlotinib Tablets
Erlotinib Tablets are indicated for the treatment of patients with metastatic non-small cell lung cancer and locally advanced,…